|

CAR-T cell infusion Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Early 1: 2

Top Sponsors

  • PersonGen BioTherapeutics (Suzhou) Co., Ltd.1
  • Dr. Zaineb Akram1

Indications

  • Cancer2
  • Relapsed Acute Lymphoblastic Leukemia (ALL)1
  • Hematolymphoid Malignancies1

Other2 trials

CAR-T Cell Therapy for ALL
Early 1
Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.